| Symbol | CRRTF |
|---|---|
| Name | CRESCITA THERAPEUTICS INC |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | H7V 0A3 Canada QC 2805 Place Louis-R-Renaud |
| Telephone | +1 450-680-4722 |
| Fax | — |
| — | |
| Website | https://www.crescitatherapeutics.com/ |
| Incorporation | CA |
| Incorporated On | 2016 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Ernst & Young LLP.; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Toronto Stock Exchange |
| CIK | — |
| Description | Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue. Additional info from OTC: |
No news found.